Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib cohort study in FLT3-ITD-positive acute myeloid leukemia
ChiCTR-OCH-14004731Phase 4Recruiting
- Sponsor
- Department of Hematology, The First Affiliated Hospital of Soochow University
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sorafenib in acute myeloid leukemia (AML) (5 arms), sponsored by Department of Hematology, The First Affiliated Hospital of Soochow University. Primary endpoints: Complete remission, Survival and 1 more. Started May 2014; status: recruiting.
02
Drugs
sorafenib
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on ChiCTR-OCH-14004731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14004731.